KR100549557B1 - 알레르겐 조성물 - Google Patents
알레르겐 조성물 Download PDFInfo
- Publication number
- KR100549557B1 KR100549557B1 KR1019997008719A KR19997008719A KR100549557B1 KR 100549557 B1 KR100549557 B1 KR 100549557B1 KR 1019997008719 A KR1019997008719 A KR 1019997008719A KR 19997008719 A KR19997008719 A KR 19997008719A KR 100549557 B1 KR100549557 B1 KR 100549557B1
- Authority
- KR
- South Korea
- Prior art keywords
- allergen
- tyrosine
- solution
- mpl
- xoa
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/35—Allergens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
조성물 | IgG1 역가 | IgG2a 역가 | IgG2b 역가 | IgE OD값 (1/10희석시) |
XOA + 티로신 | 102400 | 100 | 200 | 0.213 |
XOA + 티로신 + MPL | 409600 | 102400 | 102400 | 0.104 |
XOA + MPL | 102400 | 200 | 400 | 0.218 |
XOA 단독 | 6400 | <100 | <100 | 0.235 |
정상 마우스의 혈청 | <100 | <100 | <100 | 0.095 |
Claims (5)
- 티로신, 알레르겐 또는 알레르겐 추출물, 및 3-DMPL을 포함하며 TH2 반응에 비하여 TH1 반응을 선택적으로 증가시킬 수 있는 약제 조성물.
- 제 1항에 있어서, 상기 알레르겐은 티로신으로 코팅되거나 그리고/혹은 티로신에 흡착되어있음을 특징으로하는 조성물.
- 삭제
- 삭제
- (a) 교차 결합제와 반응시켜 알레르겐을 (임의로) 변형시키는 단계, (b) 강산수용액에서 티로신용액과 상기 임의로 변형된 알레르겐 수용액을 혼합시키는 단계, (c)상기 용액 혼합물을 중화시켜 티로신과 변형된 알레르겐을 공침전시키는 단계, (d) 그 산물과 3-DMPL을 혼합하는 단계, 및 (e) 임의로 생리학적으로 수용가능한 운반제를 첨가하는 단계, 를 포함하는 청구항 1 또는 2에의한 조성물 제조 방법.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9706957.9A GB9706957D0 (en) | 1997-04-05 | 1997-04-05 | Formulation |
GB9706957.9 | 1997-04-05 | ||
PCT/EP1998/002138 WO1998044947A1 (en) | 1997-04-05 | 1998-04-03 | Allergen formulation |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010005651A KR20010005651A (ko) | 2001-01-15 |
KR100549557B1 true KR100549557B1 (ko) | 2006-02-08 |
Family
ID=10810358
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019997008719A KR100549557B1 (ko) | 1997-04-05 | 1998-04-03 | 알레르겐 조성물 |
Country Status (17)
Country | Link |
---|---|
US (2) | US7718178B2 (ko) |
EP (1) | EP0975364B1 (ko) |
JP (1) | JP4331798B2 (ko) |
KR (1) | KR100549557B1 (ko) |
AR (1) | AR011707A1 (ko) |
AT (1) | ATE268607T1 (ko) |
AU (1) | AU729631B2 (ko) |
CA (1) | CA2285928C (ko) |
CO (1) | CO4940482A1 (ko) |
DE (1) | DE69824405T2 (ko) |
ES (1) | ES2218819T3 (ko) |
GB (1) | GB9706957D0 (ko) |
NZ (1) | NZ337580A (ko) |
PT (1) | PT975364E (ko) |
TW (1) | TWI240628B (ko) |
WO (1) | WO1998044947A1 (ko) |
ZA (1) | ZA982851B (ko) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9706957D0 (en) * | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
GB9820525D0 (en) * | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
CN1775701B (zh) * | 2004-11-16 | 2010-05-26 | 鸿富锦精密工业(深圳)有限公司 | 具有超硬镀膜的模仁 |
GB201106802D0 (en) | 2011-04-21 | 2011-06-01 | Allergy Therapeutics Ltd | Process for preparing vaccine composition |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1128637A (en) | 1966-09-13 | 1968-09-25 | Beecham Group Ltd | Influenza vaccine |
US3541201A (en) * | 1968-12-18 | 1970-11-17 | Ethan Alan Brown | Novel sodium chloride encapsulated injectionable substances |
GB1377074A (en) * | 1971-07-13 | 1974-12-11 | Beecham Group Ltd | Process for preparing injectable compositions |
US4070455A (en) * | 1974-02-16 | 1978-01-24 | Beecham Group Limited | Process for preparing injectable desensitizing compositions and products thereof in microparticle form |
GB1492973A (en) * | 1974-02-16 | 1977-11-23 | Beecham Group Ltd | Process for preparing injectable compositions |
EP0182442B2 (en) | 1978-12-22 | 1996-04-03 | Biogen, Inc. | Recombinant DNA molecules and their method of production |
US4258029A (en) | 1979-04-23 | 1981-03-24 | Connaught Laboratories Limited | Synthetic adjuvants for stimulation of antigenic responses |
US4528029A (en) * | 1980-07-21 | 1985-07-09 | Board Of Control Of Michigan Technological University | Self-reducing iron oxide agglomerates |
US4987237A (en) * | 1983-08-26 | 1991-01-22 | Ribi Immunochem Research, Inc. | Derivatives of monophosphoryl lipid A |
GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
US5244663A (en) * | 1987-01-28 | 1993-09-14 | Medibrevex | Therapeutic method against allergy |
FR2621916B1 (fr) * | 1987-10-19 | 1990-03-09 | Bioeurope | Derives de la l-tyrosine solubles dans l'eau et procede pour leur preparation |
US4912094B1 (en) * | 1988-06-29 | 1994-02-15 | Ribi Immunochem Research Inc. | Modified lipopolysaccharides and process of preparation |
GB9106048D0 (en) | 1991-03-21 | 1991-05-08 | Smithkline Beecham Biolog | Vaccines |
EP0640347A1 (en) | 1992-03-03 | 1995-03-01 | Daiichi Pharmaceutical Co., Ltd. | Oral vaccine |
PT761231E (pt) * | 1992-06-25 | 2000-06-30 | Smithkline Beecham Biolog | Composicao de vacina contendo adjuvantes |
EP1175912A1 (en) * | 1993-03-23 | 2002-01-30 | SmithKline Beecham Biologics SA | Vaccine compositions containing 3-O deacylated monophosphoryl lipid A |
AU676340B2 (en) | 1993-05-25 | 1997-03-06 | Wyeth Holdings Corporation | Adjuvants for vaccines against respiratory syncytial virus |
CA2167691A1 (en) | 1993-08-27 | 1995-03-02 | Martin J. Blaser | Campylobacter jejuni antigens, and methods for their production and use |
GB9326253D0 (en) * | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
US5997873A (en) * | 1994-01-13 | 1999-12-07 | Mount Sinai School Of Medicine Of The City University Of New York | Method of preparation of heat shock protein 70-peptide complexes |
US5646115A (en) * | 1994-10-07 | 1997-07-08 | Heska Corporation | Ectoparasite saliva proteins and apparatus to collect such proteins |
AU4977896A (en) | 1995-02-17 | 1996-09-04 | Immunotherapy, Inc. | Immunotherapy screening, prognosis, and treatment methods and compositions |
GB9508785D0 (en) * | 1995-04-29 | 1995-06-21 | Smithkline Beecham Plc | Novel compositions |
US5762943A (en) * | 1996-05-14 | 1998-06-09 | Ribi Immunochem Research, Inc. | Methods of treating type I hypersensitivity using monophosphoryl lipid A |
US5973128A (en) * | 1996-11-22 | 1999-10-26 | The Hospital For Sick Children Research And Development Lp | Glycolipid mimics and methods of use thereof |
US6491919B2 (en) | 1997-04-01 | 2002-12-10 | Corixa Corporation | Aqueous immunologic adjuvant compostions of monophosphoryl lipid A |
NZ338101A (en) | 1997-04-01 | 2002-03-28 | Corixa Corp | Adjuvant compositions of Monophosphoryl Lipid A (MPL) and a phospholipid based surfactant (1,2-Dipalmitoyl-sn-glycero-3-phosphocholine (DPPC)) suitable for intranasal administration |
GB9706957D0 (en) * | 1997-04-05 | 1997-05-21 | Smithkline Beecham Plc | Formulation |
AU7983198A (en) | 1997-06-23 | 1999-01-04 | Ludwig Institute For Cancer Research | Improved methods for inducing an immune response |
GB9717953D0 (en) | 1997-08-22 | 1997-10-29 | Smithkline Beecham Biolog | Vaccine |
GB9720585D0 (en) | 1997-09-26 | 1997-11-26 | Smithkline Beecham Biolog | Vaccine |
WO1999024577A1 (en) | 1997-11-10 | 1999-05-20 | Statens Serum Institut | NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
GB9812613D0 (en) | 1998-06-11 | 1998-08-12 | Smithkline Beecham Biolog | Vaccine |
WO1999066043A1 (en) | 1998-06-12 | 1999-12-23 | Smithkline Beecham Biologicals S.A. | Recombinant production of toxoplasma sag1 antigen |
GB9820525D0 (en) * | 1998-09-21 | 1998-11-11 | Allergy Therapeutics Ltd | Formulation |
US6734172B2 (en) | 1998-11-18 | 2004-05-11 | Pacific Northwest Research Institute | Surface receptor antigen vaccines |
ES2173679T3 (es) | 1999-01-27 | 2002-10-16 | Idea Ag | Inmunizacion/transporte transnasal con vehiculos altamente adaptables. |
EP2275133A1 (en) | 1999-02-26 | 2011-01-19 | Novartis Vaccines and Diagnostics, Inc. | Use of bioadhesives and adjuvants for the mucosal delivery of antigens |
GB9909077D0 (en) | 1999-04-20 | 1999-06-16 | Smithkline Beecham Biolog | Novel compositions |
EP1173573A1 (en) | 1999-04-23 | 2002-01-23 | Pharmexa A/S | Method for down-regulating il5 activity |
UA81216C2 (en) | 1999-06-01 | 2007-12-25 | Prevention and treatment of amyloid disease | |
GB9924529D0 (en) | 1999-10-15 | 1999-12-15 | Smithkline Beecham Biolog | Novel compounds |
GB0000891D0 (en) | 2000-01-14 | 2000-03-08 | Allergy Therapeutics Ltd | Formulation |
-
1997
- 1997-04-05 GB GBGB9706957.9A patent/GB9706957D0/en active Pending
-
1998
- 1998-04-02 AR ARP980101508A patent/AR011707A1/es active IP Right Grant
- 1998-04-03 CA CA002285928A patent/CA2285928C/en not_active Expired - Lifetime
- 1998-04-03 WO PCT/EP1998/002138 patent/WO1998044947A1/en active IP Right Grant
- 1998-04-03 JP JP54240898A patent/JP4331798B2/ja not_active Expired - Lifetime
- 1998-04-03 AT AT98919258T patent/ATE268607T1/de active
- 1998-04-03 ZA ZA9802851A patent/ZA982851B/xx unknown
- 1998-04-03 DE DE69824405T patent/DE69824405T2/de not_active Expired - Lifetime
- 1998-04-03 KR KR1019997008719A patent/KR100549557B1/ko not_active IP Right Cessation
- 1998-04-03 AU AU72160/98A patent/AU729631B2/en not_active Expired
- 1998-04-03 EP EP98919258A patent/EP0975364B1/en not_active Expired - Lifetime
- 1998-04-03 ES ES98919258T patent/ES2218819T3/es not_active Expired - Lifetime
- 1998-04-03 CO CO98018888A patent/CO4940482A1/es unknown
- 1998-04-03 NZ NZ337580A patent/NZ337580A/en not_active IP Right Cessation
- 1998-04-03 PT PT98919258T patent/PT975364E/pt unknown
- 1998-04-07 TW TW087105161A patent/TWI240628B/zh not_active IP Right Cessation
-
2005
- 2005-01-21 US US11/040,952 patent/US7718178B2/en not_active Expired - Fee Related
-
2010
- 2010-03-29 US US12/749,326 patent/US8105605B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US20100183659A1 (en) | 2010-07-22 |
PT975364E (pt) | 2004-09-30 |
DE69824405T2 (de) | 2004-10-07 |
AU729631B2 (en) | 2001-02-08 |
ATE268607T1 (de) | 2004-06-15 |
KR20010005651A (ko) | 2001-01-15 |
DE69824405D1 (de) | 2004-07-15 |
TWI240628B (en) | 2005-10-01 |
WO1998044947A1 (en) | 1998-10-15 |
CA2285928C (en) | 2008-07-08 |
US7718178B2 (en) | 2010-05-18 |
JP2001519797A (ja) | 2001-10-23 |
US20050123570A1 (en) | 2005-06-09 |
CO4940482A1 (es) | 2000-07-24 |
US8105605B2 (en) | 2012-01-31 |
AU7216098A (en) | 1998-10-30 |
GB9706957D0 (en) | 1997-05-21 |
NZ337580A (en) | 2001-04-27 |
EP0975364B1 (en) | 2004-06-09 |
ZA982851B (en) | 1999-10-04 |
AR011707A1 (es) | 2000-08-30 |
CA2285928A1 (en) | 1998-10-15 |
JP4331798B2 (ja) | 2009-09-16 |
ES2218819T3 (es) | 2004-11-16 |
EP0975364A1 (en) | 2000-02-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100642877B1 (ko) | 면역치료에 유용한 항원조성물 | |
DE69534670T2 (de) | Immunstimulierende zusammensetzungen,die ein minerales salz und ein weiteres adjuvant enthalten | |
JP3583421B2 (ja) | IgEの不変部の一部を含有するIgE媒介アレルギー反応治療用ワクチン | |
JP2010265330A6 (ja) | 処方物 | |
US4816253A (en) | Novel mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent | |
US4567041A (en) | Mutant strain of Listeria monocytogenes and its use in production of IgM antibodies and as an immunotherapeutic agent | |
US8105605B2 (en) | Allergen formulation | |
US4845042A (en) | Adjuvant for immunization | |
KR101058350B1 (ko) | 알러지 백신 조성물, 그 생산방법 및 알러지 치료에있어서의 그것의 사용 | |
DE60032119T2 (de) | Bakterienwandfraktionen mit adjuvansaktivität | |
CA2525615C (en) | Vaccine composition comprising iron phosphate as a pharmaceutical aid to said vaccine | |
AU2003268581B2 (en) | Formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130107 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20140106 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20150106 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20160104 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20170102 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20180103 Year of fee payment: 13 |
|
EXPY | Expiration of term |